학술논문
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2
Document Type
Article
Author
Smit, M.J.; Ariaans, M.B.P.A.; Wertheim, H.F.; McCall, M.B.B.; Mordmüller, B.G.; ter Heine, R.; Sander, A.F.; Fougeroux, C.; de Jongh, W.A.; Erdogan, S.M.; Gustavsson, T.; Theander, T.G.; Salanti, A.; Nielsen, M.A.; Heinzel, C.; Fendel, R.; Esen, M.; Kremsner, P.G.; Idorn, M.; Paludan, S.R.; Underwood, A.P.; Binderup, A.; Ramirez, S.; Bukh, J.; Soegaard, M.; Clemmensen, S.; Hamborg, M.; Riis Paludan, S.; Dagil, R.; Goksøyr, L.; Hulen, T.M.; Janitzek, C.; Jensen, D.S.; Justesen, S.; Khalifé, P.K.; Kreidenweiss, A.; Lança, T.; Lie-Andersen, O.; Teelen, K.; Vidal-Calvo, E.
Source
In: The Lancet Microbe . (The Lancet Microbe, March 2023, 4(3):e140-e148)
Subject
Language
English
ISSN
26665247